Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Clara Mbe Costa"'
Autor:
Ana Angelica Araujo, Acy Telles de Souza Quixadá, Silvia Maria Meira Magalhães, Jacqueline Holanda de Souza, Clara Mbe Costa
Publikováno v:
Blood. 114:4287-4287
Abstract 4287 Resistance to imatinib has emerged as a common management problem that has been addressed first by dose escalation and later by the use of second generation tyrosine kinase inhibitors (2TKI). In about half the cases the basis for acquir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a7ad92e7d659fc97df11eda9c1a7738
https://doi.org/10.1182/blood.v114.22.4287.4287
https://doi.org/10.1182/blood.v114.22.4287.4287
Autor:
Ana Cs Pinto, Ana Cristina C. Villani França, Victor H. R. L. Pereira, Carlos S. Chiattone, Luciane Valdez, Clarisse Lopes de Castro Lobo, Renato Tavares, Abrahão Elias Hallack Neto, Aderson S Araujo, Sonia Mp Cruz, Viviani Pessoa, Joao Ricardo Friedrisch, Ana Alb Araújo, Dario I. Nicolau, Liane Esteves Daudt, Rodolfo D. Cançado, Maria C. Favarin, Jaqueline C. Peres, Clara Mbe Costa, Lúcia M. R. Silla, Denise Menezes Brunetta, Camila Lnso Moreira, Denise Lehugeur, Silvia Maria Meira Magalhães, Aminadab F. Sousa, Antonio Fabron, Edna K. Carboni, Ivan L. Angulo, Carolina A S Cunha, Jose E. Nicolau
Publikováno v:
Blood. 114:5096-5096
Abstract 5096 Background Deferasirox is a once-daily oral iron chelator with established dose-dependent efficacy for treating transfusional iron overload. The retrospective multicenter Brazilian trial included patients (pts) from 14 sites of 10 state
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bbae2fc55289be5d79c5d2399133bebc
https://doi.org/10.1182/blood.v114.22.5096.5096
https://doi.org/10.1182/blood.v114.22.5096.5096